Clinical Trials
5 trialsNCT00341497 2025-07-31
Biomarkers for Oral Cancer
National Institutes of Health Clinical Center (CC)
Completed
NCT00099021 2022-02-11
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
NCT00330382 2014-12-19
Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed
NCT01238185 2013-08-12
Aspirin Mouthwash in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 1 Completed
NCT00369174 2013-02-13
Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia
National Cancer Institute (NCI)
Phase 2 Completed